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Abstract
Lytic or lysogenic infections by bacteriophages drive the evolution of enteric bacteria. Enterohemorrhagic Escherichia coli
(EHEC) have recently emerged as a significant zoonotic infection of humans with the main serotypes carried by ruminants.
Typical EHEC strains are defined by the expression of a type III secretion (T3S) system, the production of Shiga toxins (Stx)
and association with specific clinical symptoms. The genes for Stx are present on lambdoid bacteriophages integrated into
the E. coli genome. Phage type (PT) 21/28 is the most prevalent strain type linked with human EHEC infections in the United
Kingdom and is more likely to be associated with cattle shedding high levels of the organism than PT32 strains. In this study
we have demonstrated that the majority (90%) of PT 21/28 strains contain both Stx2 and Stx2c phages, irrespective of
source. This is in contrast to PT 32 strains for which only a minority of strains contain both Stx2 and 2c phages (28%). PT21/
28 strains had a lower median level of T3S compared to PT32 strains and so the relationship between Stx phage lysogeny
and T3S was investigated. Deletion of Stx2 phages from EHEC strains increased the level of T3S whereas lysogeny decreased
T3S. This regulation was confirmed in an E. coli K12 background transduced with a marked Stx2 phage followed by
measurement of a T3S reporter controlled by induced levels of the LEE-encoded regulator (Ler). The presence of an
integrated Stx2 phage was shown to repress Ler induction of LEE1 and this regulation involved the CII phage regulator. This
repression could be relieved by ectopic expression of a cognate CI regulator. A model is proposed in which Stx2-encoding
bacteriophages regulate T3S to co-ordinate epithelial cell colonisation that is promoted by Stx and secreted effector
proteins.
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Introduction
Bacteria such as Escherichia coli that colonise the mammalian
gastrointestinal tract are exposed to high levels of bacterial viruses,
bacteriophages [1]. Many bacteriophages inject their genetic
material and use the bacterial host simply to produce more phage
in a lytic cycle. Other, temperate phages, can insert their genetic
material into the bacterial genome [1–4]. In this lysogenic state the
phage genome is amplified along with the dividing bacteria [4].
Lysogenic phages have evolved to initiate their replication and
escape from the bacterial host by using the stress or SOS response
of the bacterium [5]. The integration of phage genomes and their
subsequent degeneration is important in the evolution of many
bacterial genera, for example Salmonella, Staphylococcus and Esche-
richia [6,7].
Typical enterohemorrhagic E. coli (EHEC) are defined by the
presence of Shiga toxin (Stx)-encoding lambdoid-like bacterio-
phages in the chromosome and the ability to form attaching and
effacing lesions on epithelial cells of the gastrointestinal tract due to
the activity of a type III secretion (T3S) system [8–11]. This
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secretion system is expressed from the locus of enterocyte
effacement (LEE) and is controlled by multiple regulatory inputs,
many through the LEE-encoded regulator (Ler). The T3S system
translocates a cocktail of effector proteins into eukaryotic cells,
many of which were introduced originally into the EHEC
chromosome encoded on prophages along with regulators that
co-ordinate effector expression with the T3S and may allow these
non-LEE encoded effectors to compete for translocation [12–15].
While many of these prophages are considered cryptic their
presence in strains with active prophages generates the constant
possibility of new bacteriophage generation and transduction [16].
The Stx bacteriophages also introduce further variation into the
strains, including the expression of different variants of Stx [17].
All Stx types belong to a family of A1B5 exotoxins comprising of a
single A subunit that is non-covalently associated with pentameric
B subunits that are responsible for toxin binding to its receptor, the
glycosphingolipid Gb3 (globotriaosylceramide; CD77) [17–19].
The A subunit of Stx is an N-glycosidase which cleaves the N-
glycosidic bond of a specific adenine residue of the 28S rRNA in
the 60S ribosomal subunit inhibiting protein synthesis [17,20].
Severe EHEC infections in humans are characterised by bloody
diarrhoea and capillary damage in the kidneys and brain as a
result of Stx activity with potential fatal consequences or long-term
morbidity [1,21,22].
Humans are generally considered to be an incidental host for
the majority of EHEC strains and it is apparent that ruminants
[23,24], in particular cattle are the main reservoir for the EHEC
serotypes associated with human infection, in particular EHEC
O157:H7 and EHEC O26:H11 [25,26]. The pathogenesis of the
organism therefore needs to be considered in the context of the
ruminant host in terms of selective factors that drive its evolution.
In contrast to the situation in humans, there is little evidence for
pathology associated with EHEC infection in mature, immuno-
competent cattle or other reservoir hosts which typically carry
EHEC asymptomatically [27,28]. This is related, in part, to
differences in Gb3 receptor distribution in cattle versus humans
and differences in how internalised toxin is trafficked in the cell
[29–31]. If phage insertion can confer an advantage to the
bacterium then this will also increase the survival chances of the
integrated phage DNA. Studies on Shiga toxin activity have
provided some insight into its possible benefits for EHEC in the
ruminant host, even though a subset of the bacteria must lyse to
release the toxin. Advantages for colonisation include the
redistribution of nucleolin to the epithelial cell surface where it
aids bacterial attachment via interaction with the bacterial outer
membrane protein intimin [32]. Stx has also been shown to have
immuno-modulatory functions, including the suppression of
inflammatory responses and repression of B cell/T cell prolifer-
ation [33,34], which could complement T3S effector repression of
innate responses [35–39].
Epidemiological studies have shown that particular strain types
emerge that are more likely to be associated with human disease.
In the USA, Clade 8 is associated with more serious human
disease [40] and in Europe particular phage types are more
commonly associated with human infections [41]. In a previous
study, Chase-Topping et al [42] investigated fecal pat samples from
481 farms throughout Scotland for the presence of E. coli
O157:H7. Three main phage types were identified, 21/28
(46%), 32 (19%), and 8 (12%). Previous research had shown that
cattle colonized at the terminal rectum can shed bacteria at high
levels leading to the concept of ‘super-shedders’ [43,44]. Low or
high-level shedding was defined by whether the E. coli O157
counts were below or above 103 CFU g21 feces respectively.
PT21/28 strains were more likely to be associated with high
shedding and PT32 with low-level shedding samples. PT21/28
strains are the predominant type associated with human infection
in the UK [44]. The initial aim of this study was to identify genetic
differences between PT21/28 and PT32 strains. The research
indicated that Stx bacteriophage carriage was different between
the two as was the regulation of T3S. This led us to determine the
impact of Stx phage lysogeny on T3S regulation in EHEC with the
conclusion that Stx2-encoding bacteriophages usurp control of this
essential colonization factor.
Results
Comparative genomic hybridization of PT 21/28 and PT
32 strains
In order to investigate genomic differences between Phage types
21/28 and 32, twelve strains (six of each type) were analysed by
comparative genomic hybridization (CGH) as detailed in Mate-
rials and Methods. These strains were chosen to include strains
originating from fecal pats with both high and low bacterial counts
(table S1). While multiple differences in gene content were
identified between the phage types (GEO accession number
GSE28838) the most consistent difference was in hybridization to
the Stx2 bacteriophage immunity region. Only one PT32 strain
from the six analyzed showed hybridization to this immunity
region in contrast to all six PT21/28 strains that were investigated
(figure 1A). The array design is based on the E. coli K-12, EDL933
and Sakai sequences (figure 1A). While EDL933 and Sakai contain
both Stx1- and Stx2-encoding prophages they do not contain an
Stx2c-encoding prophage. Previous characterization of the strain
collection by the Scottish E. coli reference laboratory had
determined that they all contained at least one type of Stx2 phage
(table S1), so to investigate whether Stx2 vs Stx2c prophages could
account for the hybridization differences, genomic DNA prepa-
rations from strains (n = 62) were analyzed for these prophages by
PCR (Materials and Methods). While the majority of all the strains
analyzed contained the Stx2c prophage (87%), the main difference
was in the distribution of Stx2 prophages. Overall, examining both
human and bovine-derived strains (table S1), 27/30 PT21/28
Author Summary
Many significant infectious diseases that impact human
health evolve in animal hosts. Our work focuses on
infections caused by strains of enterohemorrhagic Esche-
richia coli (EHEC) that cause bloody diarrhoea and life
threatening kidney and brain damage in humans as an
incidental host, while ruminants are a reservoir host. EHEC
strains are infected with bacteriophages that can integrate
their genetic material into the bacterial chromosome. This
includes genes for the production of Shiga toxins (Stx) that
are responsible for the severe pathology in humans. It has
been demonstrated that certain EHEC strains are more
likely to be associated with human disease and ‘super-
shedding’ animals. The current study has shown that these
EHEC strains are more likely to contain two related Stx
bacteriophages, rather than one, and that the intercalating
bacteriophages take control of the bacterial type III
secretion system that is essential for ruminant coloniza-
tion. We propose that this regulation favours co-acquisi-
tion of other genetic regions that encode type III-secreted
proteins and regulators that can overcome this control.
This finding helps our understanding of EHEC strain
evolution and indicates that selection of more toxic strains
may be occurring in the ruminant host with important
implications for human health.
Stx Phage Control of T3S
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strains contained both an Stx2 and Stx2c-encoding prophage,
compared with 9/32 of the PT32 strains analysed (P,0.01). This
difference was still significant when examining bovine strains only
(P,0.01) (table S1). It was interesting to note however that PT32
strains from humans were more likely (p = 0.01) to contain a Stx2-
encoding prophage than the PT32 bovine isolates (75% versus
25%), while the majority of 21/28 strains from either source
contained a Stx2-encoding prophage (table S1). So overall, PT21/
28 strains, which are the main human disease associated phage
type in the United Kingdom, generally harbor both Stx2 and
Stx2c phages whereas PT32 strains were more likely to contain
only a single Stx2 or Stx2c-encoding prophage, but with some
further selection for Stx2-encoding prophages in the human-
derived isolates.
T3S regulation in PT 21/28 and PT 32 strains
The secretion profiles of thirty strains of each phage type were
analysed, including western blotting for the translocon protein
EspD (a subset of strains is shown in figure 1B). From these initial
profiles it was evident that more PT32 strains were secreting
higher levels of EspD. The strains also produced variable levels of
EscJ, with higher levels of the T3S apparatus protein EscJ
correlating with higher levels of EspD secretion (figure 1B). In
order to quantify any differences in the expression of the T3S
Figure 1. Comparison of EHEC O157 PT 21/28 and PT32 strains. (A) Comparative genome hybridisation of six PT21/28 and six PT32 strains.
From left to right the PT21/28 strains are: 09807, 13425, 09064, 11204, 16438 & 17482; the PT32 strains are: 11805, 16117, 177706, 17478, 17489 &
08997 (table S1). The heat map shown indicates relative hybridisation levels of the defined strains to the Stx2 phage genome and flanking gene
sequences from the O157:H7 Sakai strain which does not contain a Stx2c prophage. Red through to orange indicates a positive hybridization signal,
with yellow a weakening signal through to blue colouration indicative of poor hybridization. All the PT21/28 strains show good relative hybridization
to the sequences especially the gam-cII immunity region that is indicated. This is not the case for the PT32 strains with only 1 showing positive
hybridisation over this same region, indicating that the remaining 5 strains are unlikely to contain the Stx2 phage. This was confirmed for the strains
using a PCR to detect Stx2 and Stx2c phage control regions (Materials and Methods), the results of which are shown under the heat map lanes. The
Stx phage distribution was then determined by PCR for 60 strains (table S1), please see Results section. (B) Western blot analysis of a subset of PT21/
28 and PT32 strains as defined (table S1). EspD was detected from bacterial supernatants and EscJ and RecA from whole cell samples prepared as
described in Materials and Methods. (C) Relative fluorescence levels from a LEE1-GFP reporter construct transformed into 14 PT21/28 and 16 PT32
strains with levels measured at OD600 = 1. The strains with mean values are defined in table S1. The median level of fluorescence from the PT32 strains
is significantly higher than for the PT21/28 (p,0.001), the variability in expression levels correlates with the Western blotting data in part B. Also
included is the overall median level (horizontal dashed line) (D) LEE1-GFP expression levels compared between strains containing either one or both
Stx2 or Stx2c prophages. Strains containing both Stx2 phages have a significantly reduced (P = 0.016) median level of LEE1 expression compared with
strains containing only one type of Stx2 prophage as determined at OD600 = 1 cultured in MEM-HEPES medium.
doi:10.1371/journal.ppat.1002672.g001
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PLoS Pathogens | www.plospathogens.org 3 May 2012 | Volume 8 | Issue 5 | e1002672
system in the two phage types, a subset of the strains (n = 31) were
transformed with a LEE1::GFP reporter construct that measures
transcription initiation of the first LEE operon including ler that
encodes a key regulator of the T3S system [45]. Fluorescence
levels were determined for the different strains during growth
curves in MEM-Hepes as defined in the Material and Methods.
For statistical analyses, fluorescence values were determined from
multiple experiments for OD600 = 1.0 (table S1). PT32 strains had
a significantly higher median level of expression compared to the
PT21/28 strains (p,0.001, figure 1C). As an alternative way of
analysing potential differences in LEE1 expression between the
PTs, the number of strains exhibiting expression levels above or
below the median value of all the readings (13,846) was compared.
On this basis, PT32 strains were more likely to express the LEE1
fusion at higher levels than the PT21/28 strains (p,0.01),
consistent with the secretion profiles and Western blotting data.
There was no association between T3S expression and single point
shedding levels of the strain obtained from the fecal pat at the time
of sampling (table S1).
Based on the observation that PT 21/28 was more likely to
contain two types of Stx2-encoding prophage (Stx2 and Stx2c) and
generally demonstrated lower levels of T3S, LEE1 expression
levels were compared with the presence of Stx2 and Stx2c
prophages. Strains containing both Stx2 and Stx2c prophages
were significantly more likely (p,0.05) to have lower LEE1
expression levels than strains containing just one Stx2 prophage
(figure 1D). The differences in T3S and LEE1 expression
appeared consistent with differences in Stx2 and Stx2c prophage
content, with more repression of T3S evident in strains containing
both Stx2 and Stx2c prophages. As only one of the PT21/28 and
PT32 strains analysed contained a Stx1 phage (table S1) it was not
possible from this data to examine any impact of Stx1 prophage
integration on T3S.
Comparison of T3S expression in the presence and
absence of Stx phages
In order to investigate whether the expression of the T3S system
is repressed by the presence of Stx prophages, secretion profiles
and LEE1 expression levels in EHEC strains, with and without
integrated Stx prophages, were analyzed. The sequenced isolate
EDL933 was compared with a published Stx1 and Stx2 prophage-
cured derivative TUV93-0 (figure 2A). Higher levels of EspD
secretion were detected in bacterial supernatants of TUV93-0
compared with EDL933 (figure 2A). This correlated with higher
levels of the apparatus protein, EscJ, in the whole cell fractions
compared with RecA as a control (figure 2A). Again, to quantify
this difference, the LEE1 promoter fusion was introduced into
both strains. The expression in TUV93-0 was higher than
EDL933 throughout the growth curve with a significance
difference for values determined at OD600 = 0.9 (figure 2B–C).
As both the EDL933 and TUV93-0 strains used have been
cultured in a number of different laboratories and EDL933 was
also subject to genetic manipulation during which phage deletion
occurred [46], there may be other genetic changes, in addition to
the absence of the Stx phages, that may account for the increased
level of T3S in TUV93-0. To investigate this, two approaches
were taken. In the first, a Stx2 bacteriophage (Sp5) marked with a
kanamycin resistance cassette from a derivative E. coli O157 Sakai
strain (Sakai stx2A::kan, table 1) was moved in the TUV93-0
background. Attempts to transduce this marked Sp5 phage into
this background were not successful. However, conjugation of the
prophage into TUV93-0 worked in the presence of a cloned and
induced copy of the Sp5 cI (pBAD-CI, table S2) to restrict
prophage induction. EspD secretion level, EscJ expression and
LEE1-GFP levels were then determined in the absence of
arabinose-induced cI induction (figure 2A–B). The conjugation
led to the repression of T3S but not to the level demonstrated for
EDL933. This repression was confirmed by analysis of both ler and
espD transcript levels in the TUV strain pair, with TUV93-0(Sp5)
showing a significant reduction in these T3S-associated transcripts
in comparison to the parent strain (TUV93-0), while there was no
significant change in gapA transcript levels between the two strains
(figure S1). As a second approach, another series of strains were
generated from EDL933 in which the Stx2-encoding prophage
and then the Stx1-encoding prophage were deleted by allelic
exchange to generate another Stx prophage negative derivative of
EDL933. This strain exhibited increased levels of T3S and LEE1
expression by comparison with the isogenic EDL933 parent, but at
lower levels than shown for TUV93-0 (figure 2A–C). Of note is
that deletion of just the Stx2-encoding prophage resulted in a
significant increase in T3S and LEE1 expression levels but that the
further deletion of the Stx1-encoding prophage had no further
impact on expression, indicating that the repression is associated
with the Stx2-encoding prophage only in EDL933. The impact of
Stx phage deletion was further confirmed by RT-PCR (figure S1),
with significantly higher espD transcript levels associated with
either the single or double prophage deletions. Taken together, it is
evident that the presence of Stx2 prophages in the EHEC O157
chromosome can limit T3S by repressing levels of LEE1
transcription. However, other uncharacterized changes between
our laboratory stocks of EDL933 and TUV93-0 may also
contribute to T3S differences between these strains.
To examine if Stx2 prophage deletion has an effect on T3S in
another EHEC serotype, two pairs of published E. coli O26:H11
strains were obtained (table 1). Both pairs are considered isogenic
apart from the presence and absence of Stx2 prophage [47], the
prophage were lost during culture of the bacteria. For one pair,
T3S increased significantly in the absence of Stx2-encoding
prophage (figure 2A), while for the other no T3S was detectable
for either strain under the conditions tested (data not shown). For
the pair with detectable T3S, the LEE1-GFP reporter was
transformed into both strains and levels of expression measured
throughout the growth curve (figure 2D). Again the presence of the
Stx2 prophage correlated with significant repression of LEE1
expression in agreement with the Western blotting profile for
EspD secretion and production of the T3S apparatus protein, EscJ
(figure 2A–C).
Repression of LEE1 promoter activity in E. coli K12
transduced with a Stx2 bacteriophage
In order to determine whether the repression of T3S expression
by Stx2 prophages could also be detected in a distinct genetic
background, the marked Stx2 bacteriophage (Sp5) induced from
E. coli O157:H7 Sakai was used to transduce E. coli K12 MG1655.
This transduction was achieved and the establishment of a lysogen
in E. coli K-12 confirmed by selectable markers and PCR assays
(Material and Methods). This E. coli K-12 Stx2 prophage lysogen
and the parental MG1655 strain were then transformed with the
LEE1::GFP promoter fusion plasmid and fluorescence levels
measured throughout the growth curve (figure 3A). While there
was some detectable expression from the LEE1 promoter there
was no significant difference in LEE1 expression levels between
the two strains (figure 3A). However, neither of these strains
contains the LEE encoded regulator (Ler) which is known to
activate T3S by relieving H-NS repression of LEE1 and other
LEE promoters. To examine the effect of the Stx2 prophage on
Ler-induction of LEE1 expression, ler was expressed from an
IPTG-inducible promoter on pWSK29 in the same pair of E. coli
Stx Phage Control of T3S
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K-12 strains containing the LEE1 reporter. Induction of Ler was
carried out using IPTG and fluorescence levels measured throughout
the growth curve. As anticipated expressing Ler in trans significantly
increased expression from the LEE1 promoter fusion in the E. coliK-
12 strain (figure 3A). However, this ler-dependent activation did not
occur to the same extent in the E. coli K-12 derivative containing the
Stx2 prophage (figure 3A). This result implied that Stx2 prophage-
based repression of T3S involved inhibition of Ler-mediated LEE1
promoter activation. To confirm that Ler was induced by IPTG
induction to a similar level in the two backgrounds, a modified Ler
was expressed from pWSK29 with a carboxy-terminal six Histidine
tag (66His-Ler) to allow levels to be determined by Western blotting.
This construct was also able to induce LEE1 expression in E. coli
MG1655 and again this activation of transcription from the LEE1
promoter was repressed by the presence of the marked Stx2 prophage
(Sp5) from Sakai (figure 3B). Whole cell protein samples were blotted
for detection of 66His-Ler and the isogenic K-12 strains containing
the LEE1-GFP reporter (figure 3E, lanes 6 & 8) contained equivalent
levels of the tagged Ler protein when compared to RecA levels as a
control. This implied that although Ler was induced and present its
capacity to act on the LEE1 promoter was limited by the presence of
the integrated Stx2 phage in the chromosome.
The lysogeny regulator CII can repress type III secretion
One explanation for the failure of Ler to induce LEE1
expression in the presence of the Stx2 lysogen is that a regulator
or regulators expressed from the Stx2 lysogen repress Ler activity
on the LEE1 promoter. Several of the key lysis/lysogeny regulators
characterized for phage lambda were cloned from the Sakai Stx2
phage (Sp5) into the arabinose-inducible vector pBAD myc HisA
(table S2). These clones were sequenced and confirmed as identical
to the published genes from Sp5. The clones were electroporated
into the Stx phage negative E. coli O157:H7 strain TUV93-0 and
the T3S profiles determined from supernatants following arabi-
Figure 2. Analysis of T3S and LEE1 expression in E. coli with and without integrated Stx prophages. (A) Western blot analysis of paired E.
coli O157 and O26 strains. EspD was detected from bacterial supernatants and EscJ and RecA from whole cell samples prepared as described in
Materials and Methods. EDL is the sequenced EDL933 strain and this was originally compared with a published strain TUV93-0 (lane 4) that has lost
both Stx1- and Stx2-encoding prophages. This strain demonstrates higher secretion levels and EscJ expression. The Stx2-encoding prophage and the
Stx1-encoding prophage were deleted from EDL933 (lanes 2 and 3 respectively) leading to increased T3S. A marked Stx2 phage [67] was conjugated
into TUV93-0 expressing a cloned cI from Sakai Sp5 (lane 5) and this resulted in a reduction in T3S and EscJ expression. The final two lanes contain
samples from a published isogenic pair of EHEC O26 strains [47] from which one has lost the Stx2 phage leading to a marked increase in T3S. (B–C) To
quantify differences in T3S expression, the same strain sets as in part A, were transformed with a LEE1-GFP construct and fluorescence measured
throughout the growth curve. This was repeated three times with one experiment shown in (B). A minimum of three values were determined from
the expression curves for OD600 = 0.9 and plotted in (C) as mean and 95% confidence intervals. *** : p,0.001 for the TUV strains and p=0.001 for the
EDL strains compared. (D) The E. coli O26 pair of strains blotted in (A) (table 1) were transformed with the LEE1-GFP expression construct or a control
plasmid and population fluorescence levels measured through the growth curve. Taken together the data demonstrates that lysogeny with an Stx2-
encoding phage represses T3S expression.
doi:10.1371/journal.ppat.1002672.g002
Stx Phage Control of T3S
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nose induction (figure 4a). Only the clone of cII showed any
evidence of T3S repression. However, it is established that CII
induction can be toxic for cells and we observed reduced growth
rates when inducing expression of cII. It is also apparent that in
this case, even though EspD levels were reduced, EscJ expression
was not, indicating a difference over the Stx2 prophage repression
phenotype. Of note was the same reduced growth rate when cII
was induced in EPEC O127 E2348/69, but in this case there was
no repression of T3S (data not shown), indicating a regulatory
difference in this Stx phage negative background. To determine
the relevance of cII to repression of T3S at physiological levels, the
cII gene was deleted sequentially from the Stx2 prophage and then
from the Stx1 prophage in E. coli O157 EDL933. Western blotting
for T3S proteins as well as fluorescence levels from the LEE1-GFP
reporter transformed into the strain demonstrated significantly
increased LEE1 expression and T3S in the absence of cII from the
Stx2 prophage (figure 4A–B), but with no further increase in
secretion following the deletion of the Stx1-prophage cII regulator.
This result is consistent with the results obtained following
sequential deletion of the Stx2 and Stx1 prophages from
EDL933 (figure 2). Available database cII sequences from Stx1-
and Stx2-encoding bacteriophages were aligned and clustered
(figure 4E). This indicated that while cII sequences can group to
some extent with Stx type, identical cII sequences can also be
associated with both Stx1 and Stx2-encoding phages. In the case
of EDL933, the BP933W (Stx2)-associated CII peptide (Z1449)
shares 94.6% amino acid identity to the predicted CII peptide
(Z3357) sequence from CP-933V (Stx1) which could account for
the differences in activity observed in this study. Both EDL933 and
Sakai also encode an additional gene within syntenic, non-stx
associated lambdoid phages (z0310 in EDL933 CP-933H
prophage and ecs0276 in Sakai Sp1 prophage, respectively), with
low predicted identity to the Stx-associated CII homologs (,30%
amino acid identity with the EDL933 Stx2 prophage CII peptide
sequence). Table S4 summarizes the results of these comparisons.
Exogenous expression of homologous cI represses Stx
prophage regulation of T3S
In the case of classic lambda, CII and the majority of prophage
regulators are silenced by CI once lysogeny has been established
[4,5]. Given that CII and potentially other regulators on Stx2/2c
prophages are involved in the repression of T3S when the
prophage is in a lysogenic state, we wanted to determine whether
increased expression of a homologous cI could alleviate this
prophage-based control by repressing the expression of these
controlling factors such as cII. This was tested in a number of
ways:
Firstly, when the marked Sakai Sp5 Stx2-prophage was
conjugated into TUV93-0 (figure 2) this required that cI from
this phage was cloned, transformed and expressed in TUV93-0 in
order to prevent zygotic induction of phage-mediated lysis on
receipt of the transferred prophage. It had already been
Table 1. Bacterial strains associated with the study.
Strain Details Source
ZAP1238 E. coli O26 Stx2+ [47]
ZAP1239 E. coli O26 Stx22 [47]
EDL933 E. coli O157:H7 EDL933 Lab stock
Stx1+ Stx2+
TUV93-0 EDL933 with excised Stx1 and Stx2 phages [46]
ZAP1321 EDL933 z1449(cIIstx2),.sacBkan. Constructed by
allelic exchange using pXLS13 (table S2)
This study
ZAP1322 EDL933DBP-933W (Stx2 phage) by allelic exchange of
ZAP1321 using pXLS15 (table S2)
This study
ZAP1323 ZAP1321Dz1449 This study
ZAP1324 ZAP1323 z3357,.sacBkan This study
ZAP1325 ZAP1324Dz3357 This study
ZAP1326 ZAP1322 CP-933V,.sacBkan This study
Sakai stx2A::kan Sequenced E. coli O157:H7 Sakai strain with a kanamycin
cassette replacing the stx2A toxin gene (Sp5 stx2A::kan)
[67]
TUV(Sp5) TUV93-0 containing a marked Stx2 phage conjugated
from JC5029(Sp5) as described in Material and Methods
This study
AAEC185 Laboratory K-12 strain for plasmid cloning [70]
E. coli K12 EDCM367 (NalR) Spontaneous NalR derivative from E. coli K12 MG1655. Provided by Prof. M. Masters, [68]
E. coli EDCM367(Sp5 stx2A::kan) Generated by transduction from the Sakai stx2A::kan strain This study
JC5029 Hfr strain E. coli Genetic Stock Center
JC5029(Sp5 stx2A::kan) Generated by transduction from the Sakai stx2A::kan strain This study
TUV93-0DgadE TUV93-0 with gadE replaced by allelic exchange [14]
E. coli O157:H7 PT21/28 and PT32 bovine isolates 38 strains isolated as part of an international partnership
in veterinary epidemiology (IPRAVE) project 2001–2006.
Further information is provided in table S1.
[42]
E. coli O157:H7 PT21/28 and PT32 human isolates 24 strains provided by Dr. Lesley Allison from the E. coli reference
laboratory, Edinburgh. Further information is provided in table S1.
Laboratory stocks
doi:10.1371/journal.ppat.1002672.t001
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demonstrated that this clone had no impact on T3S in TUV93-0
in the absence of a Stx2 prophage (figure 4), but when this cI-
encoding plasmid was subsequently displaced from the TUV93-
0(Sp5) background, there was further suppression of T3S as
determined by a reduction in EspD secretion levels (figure 5A).
The presence of the CI-encoding plasmid was therefore limiting
the capacity of the bacteriophage to repress T3S.
Secondly, the same Sakai (Sp5) cI construct was then transformed
into both E. coliO157 Sakai and EDL933 backgrounds. While there
was no detectable impact of the regulator on T3S in EDL933 (data
not shown), the expressed regulator increased levels of T3S in the
Sakai background (figure 5B). This was consistent with the fact that
the Sakai Sp5 produces a CI regulator that is markedly different
(52/217 identity, 24%) to that encoded by the Stx2 prophage (BP-
933W) of EDL933.
Finally, in order to test whether the prophage-based regulation
contributed to repression of T3S in the original PT21/28 isolates
that contain both Stx2 and Stx2c prophages (figure 1), the Sakai
Sp5 cI clone was transformed into the PT21/28 strain 15602 (table
S1). Sequencing of amplified cI alleles from this strain (Material
and Methods) indicated that it contains an identical cI to that
present in Sakai Sp5. The presence of the Sp5 cI clone and further
induction with arabinose increased EspD secretion in this PT21/
28 strain (figure 5C), supporting the concept that increased
expression of a homologous cI can counteract the activity of Stx2
prophage-based regulators, including cII, that repress T3S.
Figure 3. An Stx2-prophage represses LEE1 activation in E. coli K-12. Induction of the LEE1-promoter in isogenic E. coli K-12 strains with and
without an integrated Stx2 (Sp5) phage. (A) A marked Stx2 phage was transduced into E. coli K-12 MG1655 as described in Materials and Methods.
Expression of the LEE1-GFP reporter, or a control GFP plasmid (GFP vector) were compared in the Stx+ and Stx2 K-12 strains with and without
induction of the LEE-encoded regulator (pWSKler) or control plasmid (pWSK29) with 1 mM IPTG. (B) This experiment was repeated four times and
fluorescence values determined at OD600 = 0.9 with the mean values and 95% confidence intervals presented. Stx2 lysogeny significantly reduced
LEE1-GFP expression levels (p,0.001 (***)) following Ler induction (black and red squares), but there was no significant difference without Ler
induction (green and blue triangles). (C–D) The experiments as above were repeated with a 66His-tagged Ler construct (pWSKler*) to enable a
comparison of Ler levels in the different backgrounds. Again the Stx2 lysogen led to significantly reduced levels (p,0.001 (***)) of population
fluorescence following Ler induction (red and black squares in (C) when compared at OD600 = 0.9 in (D - presented as mean and 95% confidence
intervals). (E) 66His-tagged Ler levels were compared with RecA in the different strains by Western blotting from whole cell samples taken at
OD600 = 0.9. Both strains containing the LEE1-GFP fusion and the induced pWSKler* contained equivalent levels of the induced 66His-tagged Ler
protein, lanes 6 & 8.
doi:10.1371/journal.ppat.1002672.g003
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Discussion
Enterohemorrhagic Escherichia coli strains are characterised by
the integration of lambdoid-like phages into their chromosome
that encode Shiga toxins [1,8,47,48]. EHEC O157 strains can be
lysogenized by different types of Stx phage, but those associated
with Stx2 and Stx2c are considered the most important in terms of
human virulence [49,50]. Some strains carry multiple Stx phages
indicating differences in phage exclusion control beyond that
characterized for classical lambda [51,52]. A key question is
whether Stx phage lysogeny confers an evolutionary advantage on
the recipient EHEC strain, and whether this might underpin the
epidemiology of EHEC O157 strains? A large epidemiological
study of farms in Scotland demonstrated that PT21/28 strains
were more likely to be associated with higher level fecal counts
compared with PT32 strains. In addition, PT21/28 strains over
that period were the most prevalent phage type associated with
human infection [41,42]. The initial aim of this study was to
compare PT21/28 and PT32 strains in terms of genomic
differences to determine how these inform the epidemiology.
Comparative genomic hybridisation (CGH) and PCR analyses
demonstrated that Stx phage carriage differed between the phage
types. PT21/28 strains generally carried both Stx2 and Stx2c
bacteriophages, irrespective of whether the strains were sourced
from cattle or humans. By contrast, nearly all the bovine PT32
strains analysed carried only the Stx2c phage. The situation for the
limited number of human PT32 strains was more complex, but
these were significantly more likely to contain a Stx2 phage in
comparison to the bovine PT32 strains. This data indicates that
strains carrying both Stx2 and Stx2c phages are more likely to be
Figure 4. The CII protein is involved in repression of T3S in EHEC O157. (A) The defined bacteriophage lysis/lysogeny regulators were
cloned into the pBAD18 vector and induced in E. coli TUV93-0 that does not contain any Stx prophages. Western blot detection of EspD from
bacterial supernatants and EscJ & RecA from whole cell samples. (B) Western blot analysis of the same proteins from E. coli EDL933 and isogenic
strains from which the Stx2 cII gene and then the Stx1 phage cII gene had been deleted by allelic exchange as described in Materials and Methods.
(C–D) Population fluorescence from the LEE1-GFP reporter, or control plasmid, were examined in EDL933 and cII deletion strains and presented in D
as mean and 95% confidence intervals. Deletion of either the single cII from the Stx2-encoding bacteriophage or both cII genes led to significant
increases (p,0.001 (***)) in population fluorescence levels at OD600 = 0.9. (E) CII phylogenetic analysis. Phylogram shows unrooted maximum-
likelihood tree of 16 publicly available cII nucleotide sequences from Stx1 (green) and Stx2/Stx2c (orange) encoding bacteriophages. Abbreviations:
EDL933, EC4115, Sakai, and TW14359 (from E. coli O157:H7 complete genomes); 11368 (from E. coli O26:H11 complete genome); BP-4795 (phage BP-
4795 from E. coli O84:H4 str. 4795/97); Min27 (phage Min27 from E. coli O157:H7 str. Min27); phi and phi-II (phages Stx1phi and Stx2phiII from E. coli
O157:H7 str. Morioka V526, respectively); phi-I (phage Stx2phiI from E. coli O157:H7 str. Okoyama); YYZ (phage YYZ-2008 from E. coli O157:H7 str.
EC970520); and 1717 (Stx2-converting phage 1717 from unspecified strain of E. coli O157:H7). Scale bar shows substitutions per site.
doi:10.1371/journal.ppat.1002672.g004
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associated with human infection. This result is in line with recently
published research on Clade 8 strains in the USA that are
considered to be more virulent. Clade 8 strains were significantly
more likely to carry both the stx2 and stx2c genes in comparison to
the other clades containing stx2c [40]. All clade 8 strains tested had
stx2, and 57.6% had stx2c. Whether this association for both relates
to differences in toxicity of the strains or other phenotypes
associated with the strains is not known, although more recent
work has indicated that levels of Stx2 production alone are likely to
be important, irrespective of lineage, in terms of association with
human clinical disease [49].
As type III secretion (T3S) is essential for cattle colonisation and
variation in regulation may be associated with differences in
shedding level from cattle [44], T3S levels of PT32 and PT21/28
strains was investigated. Levels of T3S varied markedly between
strains in agreement with our previous work on T3S profiles of
EHEC O157 strains [53]. T3S levels were low in the majority of
PT21/28 strains compared with the PT32 strains. Extensive
research has defined multiple regulatory inputs for T3S and it is
likely that the variation observed will be due to a complex
combination of alleles. For example, use of a LEE1 reporter
readout in different lineages of EHEC O157 strains has yielded a
complex and widely distributed pattern of expression with no clear
association with particular integrated O-islands or S-loops [54].
However, the finding in the present study that strains with both
Stx2 and Stx phages had on average lower levels of LEE1
expression than strains with a single type of Stx2 bacteriophage
prompted us to test strain pairs with and without Stx bacterio-
phages. Analysis of these strains demonstrated that Stx2 phage
insertion into the chromosome leads to repression of T3S, this was
also apparent in a pair of O26 strains, including one from which
the Stx2 phage had been naturally cured [47]. As stated there are
likely to be multiple variable inputs into T3S expression and this
was confirmed by analysis of the potentially isogenic EDL933 and
TUV93-0 strains. While Stx2 bacteriophage insertion and deletion
repressed and activated T3S respectively, other differences
between the strains may also account for the marked difference
in T3S levels between these strains.
To confirm and study the Stx2 bacteriophage repression in
another background, the sequenced E. coli K12 MG1655 strain
was lysogenised with a marked Stx2 phage from the sequenced E.
coli O157:H7 Sakai strain. This set of experiments provided insight
into the mechanism of the Stx2 prophage control as the capacity of
Ler to induce LEE1 expression was reduced in the presence of the
Stx2 lysogen despite equivalent levels of the Ler protein being
present. In turn, this will limit expression of the other LEE operons
under Ler control reducing T3S levels from the EHEC lysogen. As
LEE1 expression is subject to auto-regulation by Ler, we cannot
rule out repression of LEE1 transcription independently of the
inhibition of Ler activation.
Of note is recently published work examining the impact of Stx
phage insertion on gene expression in E. coli K-12 by micro-array
[55]. There were 166 genes found to be differentially expressed
indicating global regulation by the integrating prophage. 62
transcripts were down-regulated and 104 up-regulated, including
motility and acid-resistance associated genes. This included
increased expression of gadE that is known to be involved in
repression of T3S so increased gadE expression following Stx
phage lysogeny could account for some of the reduced expression
[14,56,57]. In the present study, this was investigated in E. coli K-
12, in which Stx2 lysogeny was demonstrated to increase gadE
expression (figure S2A), but in an E. coli O157 background, the
deletion of gadE had no impact on the capacity of the integrated
Stx2 prophage to repress T3S (figure S2B), indicating that while
this pathway may be relevant for the prophage control, it is not
required.
Previous work has established that the LEE2/3 operons, but not
LEE1 are subject to repression by LexA in EPEC with activation
following SOS induction [58]. The repression of Ler activity on
LEE1 demonstrated in the present study may be the result of
established lambda lysogeny regulators and/or regulators encoded
elsewhere in the bacteriophages. To test established lambda phage
regulators, cI, cII, cro, anti-terminators N and Q were cloned and
induced in TUV93-0. CI was a potential regulator as this is the
main phage encoded-protein known to be expressed constitutively
during lysogeny [52] but its induction had no direct impact on
Figure 5. Homologous cI expression represses prophage control of T3S. Western blot of Secreted EspD and whole cell pellet RecA levels
(preparation control) for the indicated strains: (A) Conjugation of a marked Sp5 Stx2-prophage from E. coli O157 Sakai was carried out into TUV93-0
containing an induced clone of Sp5 cI to prevent zygotic induction. This pBAD-CI clone was then displaced with a variant of pBR322. The cI clone
limited the repressive impact of the Sp5 prophage on T3S. (B) E. coli O157 Sakai was transformed with both pBAD18 and pBAD-CI. The presence of
pBAD-CI with or without arabinose induction increased the level of EspD secretion. (C) An E. coli O157 PT21/28 isolate (15602, table S1) was
transformed with both pBAD18 and pBAD-CI. The presence of the pBAD-CI clone led to detectable EspD secretion that was increased on induction of
cI. There was no increase in T3S when the same plasmid was induced in E. coli O157 EDL933 (data not shown), indicating that the induction may be
specific to strains containing a cognate cI on the Stx2-encoding bacteriophage.
doi:10.1371/journal.ppat.1002672.g005
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T3S in the absence of an integrated Stx prophage. CII was the
only induced regulator that had a direct effect in this background,
and de-regulated CII expression is known to have effects on
growth rate [59] and so the T3S changes may have been due to
indirect effects. For example, ClpX activity is increased in stressed
bacteria and this is known act predominately on LEE4/5 and so
would affect T3S levels of the LEE4-encoded EspD but not EscJ
expressed from LEE3 [60]. To test the potential importance of cII,
both copies were sequentially deleted from the Stx2- and then
Stx1-encoding prophages in EDL933. T3S was increased follow-
ing deletion of cIIStx2 but no further increase was measured on
further deletion of cIIStx1, indicating a role of cIIStx2 in the control
of T3S regulation. This result is however incongruous with the
established regulation and function of CII, which is thought to
primarily aid the establishment of the lambda lysogen [52]. While
this is the case for bacteriophage lambda there may well be
differences in the regulation between classic lambda and Stx
lambdoid bacteriophages; for example it is already clear that these
phages are tolerant of multiple lysogens [51]. Further confirmation
that the repression of T3S is controlled by Stx2 phage-based
regulators such as CII that are under the control of CI was shown
by increasing expression of a cognate cI in a number of EHEC
backgrounds which led to an increase in T3S levels (Figure 5A–C).
We cannot rule out that other Stx2 bacteriophage-based regulators
may also contribute to repression of T3S following lysogeny but
both cI and cII sequence variation, as well as differences in their
expression and potential to cross-talk with other Stx-encoding
prophages are likely to account for the different repressive
capacities of Stx-encoding phages and T3S variation between
EHEC strains.
So why is this repression of T3S associated with Stx phage
lysogeny? We propose that Stx phages repress LEE1 expression
to effectively take control of this critical colonisation factor. The
Stx bacteriophage, through this regulation, may ensure that
bacterial colonisation and persistence become dependent on the
bacteriophage. It is interesting that EHEC strains, by comparison
with the sequenced EPEC strain O127:H6 have a greater
number of T3S effector proteins expressed from a variety of
cryptic prophages [8,61]. These effector proteins have their
expression co-ordinated with production of the T3S system by
the PchA/B regulators and Ler that act on both effector protein
expression and LEE1 [12,13]. We propose that the repression
demonstrated by Stx2 phages could select for co-integration of
effector-encoding prophages and their associated LEE regulators
(figure 6A–C). As a consequence, it is the network of prophage-
based repressors and activators controlling T3S that is important
for EHEC strains for which Stx2 prophages must also be taken
into consideration [13].
It is also evident that Stx phages provide a selective advantage
in EHEC strains for colonisation and persistence through the
production of Shiga toxins. SOS induction in the gastrointestinal
tract will lead to lysis of a subset of the bacteria with Stx release
(figure 6D). Stx allows increased expression and relocation of
nucleolin and other receptors to the epithelial cell surface where
they bind to the EHEC adhesin, intimin promoting EHEC
colonization [32,62]. This function of Stx directly links Stx phage
regulation and LEE-promoted adherence, as intimin is expressed
from the LEE and is necessary for intimate attachment and
attaching and effacing (A/E) lesion formation by binding to the
translocated intimin receptor (Tir) also expressed from the LEE
and secreted by the T3S system. It is established that EHEC
strains vary markedly in their capacity to produce Stx toxins [49],
a phenotype that is intricately associated with Stx phage carriage
and levels of lysis induction. EHEC strains also vary in their
capacity to secrete T3 translocon and effector proteins [45,53] a
phenotype that can now also be related, in part, to the
combination of Stx phages carried by a strain. The heterogeneous
nature of lysis induction means there is a subset of bacteria that
do not lyse and which can then induce T3S when appropriate
niche signals are detected, including quorum sensing [63]; these
bacteria benefit from Stx priming of the epithelium as a result of
the lysed population (figure 6D). In this way, the Stx phage and
effector prophage repertoire of an EHEC strain are critical
factors governing colonization of the gastrointestinal tract and
subsequent innate responses that will determine excretion levels
from the animal (figure 6D). Future work will examine whether
increased excretion of strains from cattle is associated with
integration of multiple Stx phages, altered T3S regulation and
increased Stx toxin levels, with important ramifications for the
selection of strains able to cause more severe infections in
humans.
Materials and Methods
Bacterial strains, plasmids, oligonucleotides and media
The bacterial strains and plasmids used in the study are
described in tables 1, S1 and S2. Table S3 lists the oligonucleotide
primers used. MEM-HEPES is minimal essential medium with
HEPES buffer (Sigma), containing additional glucose to a final
concentration of 0.2%. LB broth was also used (Oxoid).
Antibiotics were included when required at the following
concentrations: chloramphenicol (C) 12.5 mg/ml, Nalidixic acid
(20 mg/ml) kanamycin (K) 25 mg/ml and ampicillin (A) 50 mg/ml,
spectinomycin (50 mg/ml) and tetracycline (15 mg/ml).
Cloning of prophage-encoded regulators
ler, cII alleles, cI, cro, anti-terminator N and Q genes were cloned
from E. coli O157 Sakai and EDL933 strains as explained in table
S2 with primer sequences described in table S3. These clones were
confirmed by sequencing (GATC Biotech). The cI alleles from
15602 were sequenced following amplification using CIseq1 and
CIseq2 primers (table S3). Clones in pBAD/HisA were induced
with 0.2% (w/v) L-arabinose when indicated.
Comparative genomic hybridization (CGH)
Genomic DNA was extracted with Invitrogen ChargeSwitch
gDNA Mini Bacteria Kit (Invitrogen). Labeling was carried out
with Bioprime Plus Array CGH Genomic Labelling System
(Invitrogen). Protocols for pre-hybridization, hybridization and
washing for ultragaps slides were from UBEC project (School of
Biosciences, University of Birmingham). The arrays were 70-mer
spotted oligonucleotides based on open reading frames from E. coli
K-12, E. coli Sakai, and E. coli EDL933. Briefly, array slides were
washed twice in Wash Buffer II (0.1% SDS, 0.16SSC), each time
for 30S. Then slides were transferred in pre-hybridization buffer
(0.1% BSA, 0.1% SDS, 56 SSC) for 120 min. After washing in
Wash Buffer II and III (0.16 SSC), the denatured hybridization
probe mixture (30% formamide, 56SSC, 0.1% SDS, 0.1 mg/ml
Salmon sperm DNA, 16Denhardt’s Solution and 80 picomoles
Cy3 and Cy5 probe) was added to slides and incubated overnight.
Next day, the array slides were washed in Wash Buffer I (0.1%
SDS, 26SSC), II and III and scanned with an Axon scanner. The
hybridization levels were analyzed using Genespring GX 7.3.1
(Agilent).
PCR to identify stx2- and stx2c-encoding bacteriophages
Genomic DNA for 62 tested strains was extracted with the
Invitrogen ChargeSwitch gDNA Mini Bacteria Kit. The concen-
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Figure 6. Regulatory scheme for prophage control of T3S and impact on cattle colonisation. (A) Schematic diagram showing that the
integrated Shiga toxin prophage represses type III secretion (T3S) by restricting Ler-mediated LEE promoter activation. Under the conditions shown
there is no expression of the PchA/B regulators associated with other integrated prophages that express effector proteins secreted by the T3S system.
(B) Repression is overridden by the activity of activators such as PchA/B that are induced following sensing of niche specific signals in the animal host.
A number of environmental signals are known to control T3S [13] including quorum sensing [63] which is proposed to contribute to the tropism of
EHEC O157 for the terminal rectum of cattle [43]. However, much less is known about whether these can act through Pch activation. PchA/B stimulate
LEE1 and Ler expression leading to production of the T3S apparatus and secretion of LEE-encoded regulators, indicated as blue circles marked ‘LEE’ in
the figure. (C) Psr regulators on effector-encoding prophages increase gadE expression leading to repression of LEE-encoded effector protein
secretion. It is proposed that this prophage regulation allows non-LEE encoded effectors (Nle) to compete for export through the T3S system [14]. (D)
A model for EHEC interaction with the epithelium. SOS stress responses result in prophage induction and Stx release in a subset of the population.
Potentially certain stresses associated with the interaction with epithelial cells may induce this response. The released toxin induces the expression
and redistribution of receptors to the epithelial cell surface [32,62]. T3S is repressed but can be induced by Pch regulators [12,13], RgdR [15] and
further controlled by PsrA/B [14] present on cryptic prophages to ensure co-ordinate T3S apparatus expression and effector protein secretion
(figure 5A–C). The induction of T3S includes intimin expression on the outer membrane of the bacteria allowing binding to Stx-induced receptors,
including nucleolin [32]. This leads to intimate attachment and lesion formation. Secreted effector proteins can repress inflammation as can Stx [33–
39]. It is proposed that the degree and nature of this modulation will be different between strains impacting on bacterial replication and therefore
the extent of excretion from the animal.
doi:10.1371/journal.ppat.1002672.g006
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tration of the genomic DNA was measured by a nanodrop. The
method of Wang et al. [64] was used to determine the presence of
stx2 and stx2c coding sequences. 100 ng of genomic DNA was used
for each PCR reaction. An amplicon of 115 bp with the respective
primers indicated the presence of an Stx2-encoding bacteriophage
while an amplicon of 124 bp with the stx2c-specific primers
indicated the presence of an Stx2c-encoding prophage.
Preparation of secreted proteins and bacterial fractions
for protein analyses
Bacteria were cultured in 30 ml of MEM-HEPES at 37uC
(200 r.p.m.) to an OD600 of 0.8 unless specifically stated. The
bacterial cells were pelleted by centrifugation at 40006 g for
15 min, and supernatants were passed through filters (0.45 mm).
Supernatant proteins were precipitated overnight with 10%
TCA, and separated by centrifugation at 40006 g for 30 min
(4uC); the proteins were suspended in 100 ml of 1.5 M Tris
(pH 8.8). The bacterial pellet was initially suspended in 50 ml
Laemmli sample buffer (Sigma) and 50 ml water. Proteins were
separated by SDS-PAGE using standard methods and Western
blotting performed as described previously [45,65]. Primary
antibodies for Western blotting were raised against the proteins
described with the source provided in brackets: a-EspD (Gift
from Prof. T. Chakraborty, University of Giessen), a-EscJ (Gift
from Dr Ando and Prof. Tobe, Osaka University), a-RecA
(Stressgen/Enzo Life Sciences).
Quantification of population fluorescence levels
Strains were electro-transformed with pAJR70–71 (table S2)
and the resultant transformants were cultured overnight in LB
broth and then diluted 1:100 into fresh, MEM-HEPES with
appropriate antibiotics. Typically, 30 ml was cultured in
Erlenmeyer flasks shaken at 200 rpm, 37uC. The optical density
of the cultures was monitored by determination of the OD600.
Cultures were sampled every hour for optical density and GFP
measurement. The total fluorescence produced by the popula-
tion was determined by analyzing 100 ml aliquots of culture with
a fluorescent plate reader (Fluostar Optima; BMG). Promoter-
less plasmid pAJR70 acted as a control for background
fluorescence.
RT-qPCR
Bacterial RNA was purified with an RNeasy kit (Qiagen) and
reverse transcribed with random primers Affinityscript (Strata-
gene). qPCR was carried out with a PowerSybr mastermix
(Applied Biosystems). The qPCR primers used are listed in table
S3. Transcript abundance was normalized to 16S rRNA and
relative transcription calculated using MxPro software (Strata-
gene).
Constructs for allelic exchange
In order to construct plasmids for chromosomal exchange,
flanking regions of the z3357, z1449 (cIIstx2) genes and Stx1 and
Stx2 phages were PCR amplified and cloned into the
temperature-sensitive plasmid pIB307 (table S2). Primer pairs
as described in table S3: z3357 up 59, z3357 up 39 and z3357
down 59, z3357 down 39; z1449 up 59, z1449 up39 and z1449
down 59, z1449 down 39; stx1 up 59, stx1 up39 and stx1 down
59, stx1 down 39; stx2 up 59, stx2 up39 and stx2 down 59, stx2
down 3 were used to amplify z3357, z1449 Stx1 phage and Stx2
phage flanking regions sequences from E. coli O157:H7
EDL933. These products were cleaned with a Invitrogen PCR
purification kit, digested with BamHI and HindIII or SacI, or
SalI, re-cleaned, and then ligated with digested pIB307 (table
S2) to obtain pXLS10, pXLS11, pXLS12 and pXLS15
containing flanking regions of z3357, z1449, stx1 phage, and
stx2 phage respectively. To produce plasmids for exchange, a
sacBkan cassette was cloned into the BamHI sites of pXLS11,
pXLS10 and pXLS12 creating pXLS13, pXLS14 and pXLS16
that would allow the chromosomal replacement of z1449, z3357
and stx1 genes respectively with a selectable marker and a
counter-selection gene.
Allelic exchange
The method of Emmerson et al. was used for allelic exchange
[66]. Plasmid pXLS13 (table S2) was transformed into EDL933
to obtain the intermediate strain with z1449 (cIIstx2) replaced by
sacBkan cassette. Briefly, pXLS13 was electroporated into
EDL933 (table 1) and cultured at 30uC on LB-C plates. Ten
transformants were inoculated into pre-warmed LB-C at 42uC
and passaged repeatedly in LB-C broth at 42uC to obtain co-
integrates. The culture was further passaged at 30uC in LB-K
broth to select for the complete exchange. The kanamycin
resistant and chloramphenicol sensitive strain was confirmed by
PCR with primer pairs z1449 59 and z1449 39 for inside of z1449,
z1449 external 59 and z1449 external 39 for outside of z1449,
sacB 59 and sacB 39 for sacBkan cassette (table S3). The resultant
strain was termed ZAP1321. ZAP1321 was then transformed
with plasmids pXLS15 and pXLS11 and allelic exchange carried
out to generate strains with Stx2 phage and z1449 (cIIstx2) clean
deletions respectively. These allelic exchanges were as above
except that the cultures at 30uC did not contain any antibiotic
selection. The required clones were identified by sensitivity to
both kanamycin and chloramphenicol and confirmed by PCR
using primer pairs: wrbA and intW plus z1503 and z1504 for the
junction sites of Stx2; stx2 59 and stx2 39 for a region inside the
Stx2 phage; z1449 59 and z1449 39 for inside of z1449 (cIIstx2),
z1449 external 59 and z1449 external 39 for outside of z1449,
sacB 59 and sacB 39 for sacBkan cassette. The clean Stx2 prophage
and z1449 deletion strains were termed ZAP1322 and ZAP1323
respectively (table 1). In order to construct a strain deleted for
both Stx1 and Stx2 phages, ZAP1322 was used to generate a
strain with the Stx1 prophage replaced with the sacBkan cassette
using pXLS16 and the exchange protocol as above. The strain
was confirmed by resistance profile and PCR with appropriate
primer pairs (table S3). The resultant strain was termed as
ZAP1326 (EDLStx1&22). To construct a strain with both z1449
(cIIstx2) and z3357 (cIIstx1) deleted, ZAP1323 was used for allelic
exchange. pXLS14 was transformed into ZAP1323 and the
exchange carried out as described above to produce strain with
z3357 replaced by a sacBkan cassette. The strain was confirmed
by antibiotic resistance profile and PCR with appropriate primer
pairs (table S3). This strain was termed ZAP1324. ZAP1324 was
electroporated with pXLS10 and the clean deletion of z3357
(cIIstx1) was obtained by allelic exchange and confirmed by
resistance profile and PCR. The final z3357 and z1449 clean
deletion was termed ZAP1325 (table 1).
Strain construction by transduction and conjugation
A marked Sp5 bacteriophage from an Stx negative variant of E.
coli O157:H7 Sakai containing a stx2A::kmr cassette [67] was
transferred to other strains by either transduction or conjugation.
For transduction, the bacteriophage were prepared by culture of
the strain in LB at 37uC followed by addition of 1 mg/ml
mitomycin C (MMC) until lysed. The culture was centrifuged to
pellet debris then chloroform used to extract bacteriophage from
the supernatant and to kill any remaining cells. This bacteriophage
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preparation was used to transduce a spontaneous Nalidixic acid
resistant strain of E. coli K12 EDCM367 [68]. Positive transduc-
tants were selected on LB agar plates containing kanamycin and
then screened on nalidixic acid. The presence of the marked Stx
prophage was further confirmed by PCR and MMC-induced lysis.
For conjugation into TUV93-0 or TUV93-0DgadE (table 1), Hfr
JC5029 (E. coli Genetic Stock Center) strain transduced with the
marked Sp5 as above was used. Spontaneous Nalr TUV93-0
strains were selected. These and JC5029(Sp5) were transformed
with pBAD-CI (table S2) to prevent zygotic induction following
conjugation and to allow the donor to grow in the presence of
ampicillin during the mating. Plate mating was carried out on LB
agar+0.2% arabinose and ampicillin. The bacteria were washed
off with LB and then selected on agar plates containing kanamycin
and nalidixic acid. The absence of the Hfr strain was confirmed by
sensitivity to spectinomycin to which JC5029 is resistant. The final
strain was confirmed to contain the marked Sp5 by PCR and lysis
following addition of mitomycin C (1 mg/ml). To remove pBAD-
CI (table S2) from TUV93-0 (Sp5) or TUV93-0DgadE (Sp5), the
strain was transformed with pBR322DScaI-SspI with selection for
tetracycline resistance and screening for sensitivity to ampicillin on
LB agar plates.
Phylogenetic analysis of CII
Phylogenetic analysis of 16 cII nucleotide sequences from
publicly available Stx1- and Stx2/Stx2c-encoding bacteriophages
was carried out by maximum likelihood as implemented in
PHYLIP (http://www.phylip.com/). Bootstrap values were calcu-
lated from 100 replicates. Sequences were obtained from both
complete bacterial genomes and complete phage genomes from
the NCBI RefSeq database (source genome accessions and cII
locus tag unique identifiers are listed with square and round
brackets, respectively); i) cII sequences from complete bacterial
genomes: E. coli O157:H7 str. EDL933 [NC_002655] Stx1 phage
(Z1449) and Stx2 phage (Z3357), E. coli O157:H7 str. EC4115
[NC_011353] Stx2 phage (ECH74115_3554) and Stx2c phage
(ECH74115_2923), E. coli O157:H7 str. Sakai (NC_002695) Stx1
phage (ECs2988) and Stx2 phage (ECs1187), E. coli O157:H7
TW14359 [NC_013008] Stx2 phage (ECSP_3270) and Stx2c
phage (ECSP_2739), E. coli O26:H11 str. 11368 [NC_013361]
Stx1 phage (ECO26_1586); ii) cII sequences from complete phage
genomes: Stx1 phage BP-4795 [NC_004813] from E. coli O84:H4
str. 4795/97 (phi4795p23); Stx2 phage Min27 [NC_010237] from
E. coli O157:H7 str. Min27 (pMIN27_28); Stx1 phage Stx1phi
[NC_004913] from E. coli O157:H7 str. Morioka V526
(Stx1_gp56), Stx2 phage Stx2phiII [NC_004914] from E. coli
O157:H7 str. Morioka V526 (Stx2II_gp57), Stx2 phage Stx2phiI
[NC_003525] from E. coli O157:H7 str. Okoyama (Stx2Ip123);
Stx1 phage YYZ-2008 [NC_011356] from E. coli O157:H7 str.
EC970520 (YYZ_gp27); and Stx2 phage 1717 [NC_011357] from
an unspecified strain of E. coli O157:H7 (Stx2-1717_gp22). With
the exception of pMIN27_28 (which contains an in-frame 3
nucleotide insertion relative to other cII sequences) all sequences
were 297 nucleotides in length and aligned without gaps.
Statistical analysis
Differences in the level of fluorescence from the PT32 strains
compared to PT21/28 strains and strains containing both Stx2 or
Stx2c prophages compared to strains only containing one were
compared by standard two-sample t-tests on log10 transformed
values. Standard two-sample t-tests were also performed to
compare relative fluorescence in specific TUV, EDL and K-12
strains. A fisher exact test was carried out to compare in PT32 and
PT21/28 strains the proportion exhibiting expression levels above
a threshold. All analyses were carried out in R ( R Development
Core Team (2009). R version 2.10.1( Foundation for Statistical
Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://
www.R-project.org.). P,0.05 was taken to indicate statistical
significance. Statistical analysis of qRT-PCR data was carried out
using REST 2009 software [69].
Supporting Information
Figure S1 Analysis of specific transcript levels in the presence
and absence of Stx prophages. (A) ler, espD and gapA (control)
transcript levels in relation to 16s rRNA from total RNA extracted
from TUV93-0 and a derivative containing the Sp5 Stx2
prophage from Sakai, conjugated into TUV93-0 as described in
Material and Methods. (B) ler, espD and gapA (control) transcript
levels were determined from EDL933 and derivatives with the
Stx1 prophage and both the Stx1 and Stx2 prophages deleted by
allelic exchange (table S2). * p,0.05, *** p,0.001.
(PDF)
Figure S2 The role of gadE in Stx phage-based repression of type
III secretion. (A) A gadE::gfp reporter (pPgadE.GFP+) and control
plasmid (pKC26) (table S2 and [14]) were transformed into E. coli
K12 and E. coli K12 (Sp5) and fluorescence measured throughout
the growth curve. Data shown is the mean of three cultures with
readings at OD420 nm= 0.9. The presence of the integrated Stx2-
prophage (Sp5) led to a significant increase (p,0.001) in gadE
expression. (B) The marked Sp5 prophage was conjugated into
TUV93-0 and the gadE mutant of this strain (table 1) and the T3S
level assessed by Western blotting for EspD. RecA levels were
monitored from the pellet as a control. The presence of the
integrated Stx2 prophage was able to repress T3S despite the
absence of gadE, indicating that an increase in gadE expression is
not responsible for the measured repression as would be
anticipated [14].
(PDF)
Table S1 EHEC O157:H7 PT21/28 and PT32 strains and
properties.
(PDF)
Table S2 Plasmids used in the study.
(PDF)
Table S3 Oligonucleotide primers used in this study.
(PDF)
Table S4 cII homologs found in O157 strains used in this study.
(PDF)
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